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Abstract. Birth asphyxia and newborn prematurity are the two major causes of perinatal mortality 
resulting in central nervous system (CNS) injury by hypoxia and ischemia. Hypoxia and ischemia 
produce massive brain damage following a typical pattern which is defined by selective vulnerability of 
the brain regions.The main objective of this study was to test the possible protective effect of  resveratrol 
and hypothermia in hypoxic-ischemic encephalopathy in newborn rats. The changes in terms of 
histology and apoptosis were determined in brain so as to assess the local damages induced by hypoxic 
ishemia. The experiment was performed on 17 newborn Wistar rats that were given resveratrol in a dose 
of 20 mg/kg/day for seven days as premedication. At the end of this period the animals were exposed to 
hypobaric hypoxia (9% O
+2
 for 90 minutes) and ischemia (by clamping the right carotid artery). In 
global hypoxic-ischemic encephalopathy the resveratrol at a dose of 20 mg/kg/day as premedication 
offers neuroprotection by reducing the number of cells expressing apoptosis in CA1, CA2, CA3 and 
dentate gyrus of the hippocampus under the conditions of conjugation with post-injury hypothermia. 
In the cerebral cortex the resveratrol protective effects were not hypothermia dependent. No protective 
effect of resveratrol was observed in thalamus after global hypoxic-ischemic encephalopathy. The 
results of this study prove that resveratrol offers neuroprotection in hypobaric hypoxic brain injuries, 
but the protection is conditioned in most of the brain regions (excepting cerebral cortex) by 
conjugation of the protective therapy with post-injury hypothermia treatment 
 




The World Health Organization statistics from 2013 indicated that premature 
newborn asphyxia (perinatal) is the major cause of perinatal mortality and results in central 
nervous system injury, hypoxic-ischemical. The determinant of brain damage and 
permanent neurological imbalance in fetuses and neonates suffering from perinatal asphyxia 
is caused by cerebral ischemia due to interruption of ventilation and oxygenation during 
birth or calving (Jhonston 2002). The immaturity of newborn CNS predisposes to oxidative 
stress, because the rise is much richer in oxygen (100 torr) as compared to adult persons 
(20-25 torr) which leads to an increased production of free radicals.  
Resveratrol (3,4,5 '- trihydroxy-trans-stilbene, C14H12O3) a natural polyphenol, 
was originally extracted from the roots of white hellebore in 1940, then in 1963 the root of 
Polygonum cuspidatum, a plant used in traditional Japanese and Chinese medicine.  
Recent studies shows that resveratrol has a role in protecting neuronal cells from 
apoptosis, particularly in degerenative diseases, holding also other beneficial effects as its 
ability to modulate the synthesis of nitric oxide and promote vasodilation, which improves 
circulation and oxygenation in the brain (Jain 2011, Baur 2006). 
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In the early 80, interest oh therapeutic effects of hypothermia was rekindled when in 
experimental models the beneficial effects of weak hypothermia (32-35 ⁰ C) compared with 
deep or moderate hypothermia (Thoresen 2005) was proowed. Post-hypoxic hypothermia 
reduces neuronal apoptosis, the production of nitric oxide free radicals and the amount of 
excitatory amino acids. The hypotermia is important in reducing the inflammation of the 
blood-brain barrier thus providing continuity in blood perfusion of the brain (Thoresen 2005).  
Hypothermia also, inhibits several stages of experimental biochemical cascade that 
causes severe brain damage after hypoxia - ischemia, in contrast to pharmacological agents 
targeting a single step in the process leading to neuronal injury.  
 
 
MATERIALS AND METHODS 
 
Experimental model. The experiment was performed on 17 newborn Wistar rats 
that were given Resveratrol in a dose of 20 mg/kg/day for seven days as premedication. 
At the end of treatment the animals were exposed to hypobaric hypoxia (9% O
+2
 for 90 
minutes) and ischemia (by clamping the right carotid artery) following a protocole 
previously described by Jain (Jain 2008). In order to test the effect of combined therapy 
of resveratrol with hypothermia Several animals were exposed after hypoxic-ischemic 
injury to whole body hypothermia (with 4
O
C). 
Histopathologic examination. The encephalon regions chosen for examination 
(Ammon's horn, dentate gyrus, thalamus and cerebral cortex from the parietal and 
temporal areas) were embedded in paraffin following the routine protocol and finaly 
stained using Hematoxylin-and Eosin technique. 
Immunohistochemestry. For identification of the neural cells which undergows apoptosi 
we used the immunohistochemical expression of the Cleaved Caspase 3 (Polyclonal Rabbit anti-
Caspase3 -Thermo Scientific-PA1-26426). The immunohistochemical reaction was performed 
using the Leica Bond-Max TM unit, using the a standard indirect avidin-biotinreaction.  
Quantification of immunohistochemical Cleaved Caspase 3. The  expression of  Cleaved 
Caspase 3  was assesed on histological sections  from all the 6 regions analyzed: cerebral cortex 
(COR), thalamus (TA), Ammon's horn (with CA1, CA2, CA3) and dentate gyrus (DG). All the 
immunopositive cells from a 36397 μm2 area  were counted and reported to the total number of 
the cells couted from thet area. The count covered both neurons and glial cells. Finally, CAS3 
expression was shown as percentage of positive cells from each examined region.  
 
 
RESULTS AND DISCUSSIONS 
 
The most affected areas of new-born rats during global ischemia-hypoxia are, in order 
of severity of lesions were, in order of severity of lesions, the dentat gyrus and subregions 
CA2, CA3 of the hippocampus. The CA1, the thalamus and cerebral cortex are less affected 
In the CA2 subregion of the hippocampus, comparing the effects of resveratrol and 
temperature (hypothermia and normotermie post injury) under ischemia/reperfusion and/or 
hypoxia, we observed the protective effect of the combination of resveratrol  and hypothermia 
(with 4
o
C) therapy under hypobaric hypoxia (O2 9 % -90 min). This effect is expressed only 
in the pyramidal cell layer (Fig. 1), being absent in the radial layer of cells. As with CA1 and 
CA2 we have found that resveratrol combined with hypothermia therapy does not provide 






Fig. 1 Caspaza3 immunohistochemical expression at the pyramidal CA3 subregion cell layer of 
Ammon's horn (left panel ), and cerebral cortex (right panel). Group I-control cerebral ischemia; IH-
ischemia-hypothermia group; IN-control group ischemia-normotermia; RIH-resveratrol-ischemia-
hypothermia group; RIN-ischemia-normotermiA- resveratrol; RH resveratrol-hypothermia; RN-
resveratrol-normotermia. Images were obtained with x40 ob. 
 
In the dentate gyrus the neuroprotective effect of premedication with resveratrol 
was observed, but this effect is employed only  if the treatment is combined with 
hypothermia. In the thalamus, assessing the effects of resveratrol and temperature 
(hypothermia vs normotermie), it is observed that resveratrol therapy does not improve the 
injuries induced by ischenia/reperfusion and hypoxia at this level.  
On the whole, we can say that resveratrol offers neuroproection in a newborn 
model of hypobaric hypoxia only in conjugation with brain hypothermia treatment. 
 
Table 1 
The median number of Caspase3 positive cells for CNS areas analyzed 
 
Group 
Examinated area (%)  
Total CA1 CA2    CA3 Cortex    GD Thal. 
SR SP SR SP     
      I 88 50 88 70 96 25 98 41 69,5 
     IH 49 48 46,3 69 90,6 17 89,6 21,6 53,8 
     IN 40 21,6 42,6 41 84 13,6 84,3 16 42,8 
   RIH 59,6 45 49,3 59,3 87,6 17,3 89,6 21,6 53,6 
   RIN 80,5 23,5 27 20,5 87 10,5 96 19,5 45,5 
     RH 50,3 32 48 60,3 90,3 11 88,3 20 50 
     RN 72,5 36,5 72 56,5 87,5 18 93,5 20,5 57,1 
 
Experimental studies on newborn  rats with induced brain ischemia and hypoxia 
demonstrates, as in our study, that hypothermia’s main protection mechanism is by 
suppressing  the caspase 3 activation (Fukuda 2001). Another study in rats demonstrates 
that intravenous resveratrol significantly decreases the volume of  ischemic area in local 
brain ischemia. In the same study, resveratrol prevent seizures and partial restores 
perception. This study also demonstrates that resveratrol is able to cross the blood-brain 
barrier and exert strong neuroprotectore even in small doses (Baur 2006). 
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One aspect observed in our study is that brain damage induced consecutive to 
hypobaric hypoxia has a heterogeneous anatomical distribution. The deep forebrain regions 
such as the hippocampus and thalamus are more affected than the cerebral cortex (table 1).  
The  distribution of the lesions in the cerebral cortex is interesting, the cells wich 
undergo apoptosis being arranged mainly in the layer I of the cortex. This is due to the fact 
that neuronal populations sensibility in brain under hypobaric hypoxia is variable and 
dependent on the duration and severity of ischemia. Ammon's horn neurons in area CA1 are 
most sensitive to depolarization due to ischemia (3-5 minutes) compared to neurons located in 
the striated layer, neurons that resists in average between 15 and 20 minutes. Regarding the 
type of neuronal cell death, necrotic lesions predominate in high intensity ischemia, whereas 
apoptosis occurs when ischemic damage is mild or moderate. Also the apoptotic lesions have 
a much more slower  progress compared with the necrotic one (Pulera  1998).  
Other studies also demonstrate the morphological and functional benefits of early 
initiation of hypothermia in conjuction with resveratrol in lobal brain ischemia and hypoxia. 
Thus, hypothermia provides neuroprotection, clinically improving the behavioral performance 
in both adults and neonates. The only complications observed due to hypothermic-theraphy 
were transient changes on heart rate and blood pressure (Gonzalez  2005).  
Studies in adults prove that hypothermia initiated immediately after cardiac arrest 
provides significant improvements and the late cooling after brain trauma appears to be 
effective. Children born at term suffering from hypoxic-ischemic encephalopathy and who 
were less severe, were exposed for 72 hours to moderate systemic hypothermia (rectal 
temperature of 34.5 ⁰ C) , and the results were promising with reduced neuronal death and 




The results of this study prove that resveratrol offers neuroprotection in hypobaric 
hypoxic brain injuries, but the protection is conditioned in most of the brain regions 
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